colonoscopy glp 1 Impact of Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) on Increased Residual Gastric Content in Patients With and Without Concurrent Colonoscopy: A Retrospective Case–Control Study GLP-1 Receptor Agonists and Gastrointestinal
Description
The researchers were able to measureGLP-1 in synovial fluid - the liquid within joint cavities - of patients with inflammatory rheumatic diseases. That matters becauseGLP-1-based therapies typically lead to much higher systemic exposure
This meta-analysis aimed to evaluate the association between GLP-1 RAs and CRC risk in patients receiving GLP-1 RAs
Diabetes mellitus is a major risk factor for both cardiovascular and chronic kidney disease (CKD) while CKD is also associated with cardiovascular morbidity
Medical Weightloss & Wellness, Inc offers semaglutide treatment
Learn if your GLP-1 drug is covered.
